Regencell Bioscience Holdings
RGC • NASDAQ • Stock Fundamentals
Regencell Bioscience Holdings is a drug manufacturers - specialty & generic company in the healthcare sector trading on NASDAQ, led by CEO Yat-Gai Au, with a market cap of $12.0B.
Market Cap$12.0B
Employees12.0
CEOYat-Gai Au
CountryHong Kong
Healthcare
Drug Manufacturers - Specialty & Generic
Most Recent EarningsNov 18, 2025 · 6 months 10 days agoQ2 2025
View reportNext EarningsJun 2, 2026 · In 5 daysBefore Market Open · Q4 2025
Financials
Based on Q2 2025 filing
Regencell Bioscience Holdings FAQ
Common questions about Regencell Bioscience Holdings
Regencell Bioscience Holdings (RGC) has a market capitalization of $12.0B and trades on NASDAQ.
Regencell Bioscience Holdings has approximately 12 employees.